Padma Portono 
INDIANAPOLIS, May 1, 2018 — Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to … Read more
Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology. The funding represents a first-time interstate collaboration between two Indiana-based investors, BioCrossroads and Elevate Ventures, together with Ohio-based Rev1 Ventures, and follows … Read more
Technology seminar by Meso Scale Discovery (MSD), January 17th, 12:30-1:30 pm at the Indiana Center for Biomedical Innovation (ICBI). MSD provides singleplex and multiplexed assays for neurodegenerative, metabolic inflammation, oncology, toxicology, cell signaling and a broad range of other disease-focused biomarkers. It is also an open platform with necessary tools to help develop assays for … Read more
Invention to Startup forum presentation by Femtera Laboratories LLC (ICBI startup company), developing cancer biomarkers using metabolomics. Title of the Talk: Metabolomics: on the way towards practical clinical application Friday, February 23rd, at 12:30pm at the Indiana Center for Biomedical Innovation (ICBI).
gener8tor a nationally ranked accelerator has branched to Indiana, plans to offer seven-week program to five Indianapolis startups at the end of April. gBETA program is free, seven-week accelerator for early-stage companies. Each program is capped at five teams, and requires no fees and no equity. The program dates are April 26th – June … Read more
Allinaire Therapeutics, a respiratory therapeutics start-up launched by BioMotiv, has recently received new investments from BioCrossroads’ Indiana Seed Fund and Indiana University’s Innovate Indiana Fund. The Funding will advance the development of therapeutics for the treatment of chronic obstructive pulmonary disorder (COPD) and other respiratory diseases. Read Now
A $3 million NIHM grant provides support for a new PTSD Medication Part 2 of a series tracking the development of a safer, new PTSD… Read Now
Theratome Bio said it plans to begin manufacturing small doses of the experimental drug and start clinical trials on patients in the first half of 2019. The plan is to administer the drugs to 24 patients who are undergoing a transaortic valve replacement, a minimally invasive surgical procedure that repairs the valve. Brain injury is … Read more
On Wednesday, November 1, 2017, several of IUPUI’S distinguished faculty scholars will showcase their translational research and illustrate how they improve people’s lives at the IUPUI TRIP Community Showcase in the IUPUI Campus Center. These scholars have partnered with community members and others to translate their research into viable practices that improve our communities. Mark … Read more
You are invited to the “Invention to Startup forum” at The Indiana Center of Biomedical Innovation (ICBI). The goal of the program is to support the advancement of translational research and lab discoveries into market-directed healthcare applications. The program is designed to provide guidance and mentorship to academic scientists. The next forum meeting is on October 27th , see information below. … Read more
